Sanofi
Price Action
Technical Summary
DOWNTRENDSanofi is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 32), showing significant lag compared to the market leaders. Earnings contraction of 5% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $42.96 | +0.05% | ABOVE |
| 50 SMA | $43.64 | -1.51% | BELOW |
| 100 SMA | $45.04 | -4.58% | BELOW |
| 150 SMA | $46.02 | -6.61% | BELOW |
| 200 SMA | $46.88 | -8.32% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SNY in an uptrend right now?
SNY has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is SNY overbought or oversold?
SNY's RSI (14) is 47. The stock is in neutral territory, neither overbought nor oversold.
Is SNY outperforming the market?
SNY has a Relative Strength (RS) Rating of 32 out of 99. SNY is currently lagging the broader market.
Where is SNY in its 52-week range?
SNY is trading at $42.98, which is 82% of its 52-week high ($52.68) and 18% above its 52-week low ($40.89).
How volatile is SNY?
SNY has a Beta of 0.41 and 52-week volatility of 27%. It's less volatile than the S&P 500 - generally more stable.